Monthly Revenue From ScripsAmerica's Managed Specialty Pharmacy Nearly Doubles in April, Topping $958,000
GlobeNewswire - Mon May 05, 8:41AM CDT
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that its managed specialty pharmacy reported $958,234 in prescription sales during the month of April, representing a 94% increase in monthly revenue over March.
ScripsAmerica's PIMD International Receives DEA License to Distribute Class 2 Through 5 Pharmaceutical Formularies
GlobeNewswire - Tue Apr 22, 7:30AM CDT
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that PIMD International, LLC has recently received a license to receive, store and ship Schedule 2 through Schedule 5 formulary pharmaceuticals in Florida and Pennsylvania.
ScripsAmerica Files 2013 Annual Report and Management Comments on Revenue Recognition
GlobeNewswire - Wed Apr 16, 7:30AM CDT
ScripsAmerica Inc. (OTCBB:SCRC) today announced that the Company has filed its 10-K Annual Report for 2013 with the Securities & Exchange Commission (SEC).
ScripsAmerica Issues Second Payment on Largest Convertible Note
GlobeNewswire - Wed Apr 02, 8:43AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has issued the second payment due on its convertible note with the largest principal and closest conversion date.
ScripsAmerica Reports March Revenue of Over $494,000 for Its Managed Specialty Pharmacy
GlobeNewswire - Tue Apr 01, 8:25AM CDT
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the specialty pharmacy it recently entered into a management agreement with recorded $494,643 in prescription sales for the month of March.
ScripsAmerica Prepays $50,000 Convertible Promissory Note
GlobeNewswire - Mon Mar 31, 7:30AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced the prepayment of an outstanding convertible note in the principal amount of $50,000.
ScripsAmerica's Pharmaceutical Equity Venture, Wholesale Rx, Continues Revenue Growth in February
GlobeNewswire - Mon Mar 24, 7:33AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's equity venture, Wholesale Rx "WRx," received and processed $313,904 in orders during the month of February.
ScripsAmerica Prepays Another Convertible Promissory Note
GlobeNewswire - Mon Mar 17, 7:30AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company has prepaid the entire balance of an outstanding convertible promissory note with a principal amount of $50,000.
ScripsAmerica Announces Prepayment of Convertible Promissory Note
GlobeNewswire - Wed Mar 12, 7:46AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company has prepaid the balance of an outstanding convertible promissory note with a principal amount of $40,000.
ScripsAmerica Secures $200,000 RapiMed Purchase Order for Hong Kong Market
GlobeNewswire - Mon Mar 10, 9:02AM CDT
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has secured a $200,000 purchase order for RapiMed(R) from Global Pharma Hub for the Hong Kong market.
ScripsAmerica Enters Licensing Agreement to Market and Distribute RapiMed in Canada
GlobeNewswire - Wed Mar 05, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a sublicensing agreement for the marketing and distribution of RapiMed(R) in Canada. ScripsAmerica will now have access to the growing Canadian OTC drug market, which was valued at over $3.1 Billion in 2012.
ScripsAmerica Signs Business Management Agreement With a New Jersey Compounding Pharmacy
GlobeNewswire - Thu Feb 20, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a business management agreement with a New Jersey compounding pharmacy.
ScripsAmerica Commences Prepayment of Convertible Notes
GlobeNewswire - Wed Feb 19, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has commenced the prepayment of its outstanding convertible debt by issuing the first payment on its convertible note with the largest principal and closest conversion date.
ScripsAmerica's Pharmaceutical Equity Venture Generates Record Revenue for Second Consecutive Month
GlobeNewswire - Wed Feb 12, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that during the month of January, the Company's equity venture, Wholesale Rx "WRx," received and processed $268,696 in orders, setting a second consecutive monthly revenue record.
ScripsAmerica's RapiMed Product Receives Registration Approval From the Hong Kong Government
GlobeNewswire - Mon Feb 10, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has received registration approval for its RapiMed(R) Children's Pain Reliever & Fever Reducer from the Government of Hong Kong.
ScripsAmerica Signs Joint Venture With Global Pharma Hub to License, Market and Distribute RapiMed in Hong Kong, China
GlobeNewswire - Mon Feb 03, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a joint venture with Global Pharma Hub, an international pharmaceutical marketing and distribution company, to license, market and distribute its RapiMed(R) Children's pain reliever and fever reducer.
ScripsAmerica's Pharmaceutical Joint Venture Generates Record Revenue in December
GlobeNewswire - Mon Jan 06, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC) today announced that the Company received and processed a record high $165,424 in orders from its pharmaceutical distribution joint venture (JV) during the month of December.
ScripsAmerica Enhances Website to Increase Shareholder Communication
GlobeNewswire - Mon Dec 30, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced the addition of a new section to the Company's website, www.scripsamerica.com, that will serve as a thorough source of shareholder information and be continuously updated by management.
Revenue from ScripsAmerica's Pharmaceutical Joint Venture on Record Pace for December
GlobeNewswire - Thu Dec 19, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has received and processed a record high $51,920 in orders during the week ending December 13, 2013 and $84,821 in orders for the first two weeks of the month from its recent pharmaceutical distribution joint venture ("JV"
ScripsAmerica's Pharmaceutical Joint Venture Generates Over $116,000 in Revenue for November
GlobeNewswire - Wed Dec 18, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has received and processed $116,987 in orders during November from its recent pharmaceutical distribution joint venture ("JV"